XBiotech Inc (NASDAQ: XBIT) stock closed at $4.14 on 12/18/23 after a major decline of -11.0%. Moreover, exceptionally high trading volume at 209% of normal accompanied the decline. The stock has been strong relative to the market over the last nine months but has declined -0.7% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be in line with the cost of capital, XBIT is expected to continue to be Value Creation neutral.
XBiotech has a current Value Trend Rating of C (Low Neutral). The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. XBiotech has a slightly negative Appreciation Score of 32 and a neutral Power Rating of 58, leading to the Low Neutral Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment